<code id='49B15B0908'></code><style id='49B15B0908'></style>

<acronym id='49B15B0908'></acronym>

<center id='49B15B0908'><center id='49B15B0908'><tfoot id='49B15B0908'></tfoot></center><abbr id='49B15B0908'><dir id='49B15B0908'><tfoot id='49B15B0908'></tfoot><noframes id='49B15B0908'>

<optgroup id='49B15B0908'><strike id='49B15B0908'><sup id='49B15B0908'></sup></strike><code id='49B15B0908'></code></optgroup>

<b id='49B15B0908'><label id='49B15B0908'><select id='49B15B0908'><dt id='49B15B0908'><span id='49B15B0908'></span></dt></select></label></b><u id='49B15B0908'></u>

~~<i id='49B15B0908'><strike id='49B15B0908'><tt id='49B15B0908'><pre id='49B15B0908'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

leisure time

author：knowledge 2025-09-06 04:43:34 Page View：1

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

advertisement

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Parkinson's study, Gilead, CG Oncology
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Stephen Quake on the Chan Zuckerberg quest to conquer disease

StephenQuake:"OurNorthStarforthenextdecadeisunderstandingthemysteriesofthecell."ChanZuckerbergInitia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

Statins may not be needed by millions of people, study suggests

AnewanalysissuggeststhatfarfewerAmericanswouldbecandidatesforcholesterol-loweringdrugstopreventcardi

read more